LAVA Therapeutics NV (LVTX)
3.05
-0.05
(-1.61%)
USD |
NASDAQ |
May 03, 16:00
3.05
0.00 (0.00%)
After-Hours: 20:00
LAVA Therapeutics Price to Book Value: 1.567 for May 3, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 02, 2024 | 1.592 |
| May 01, 2024 | 1.526 |
| April 30, 2024 | 1.484 |
| April 29, 2024 | 1.490 |
| April 26, 2024 | 1.402 |
| April 25, 2024 | 1.356 |
| April 24, 2024 | 1.408 |
| April 23, 2024 | 1.531 |
| April 22, 2024 | 1.464 |
| April 19, 2024 | 1.392 |
| April 18, 2024 | 1.454 |
| April 17, 2024 | 1.510 |
| April 16, 2024 | 1.484 |
| April 15, 2024 | 1.505 |
| April 12, 2024 | 1.608 |
| April 11, 2024 | 1.716 |
| April 10, 2024 | 1.562 |
| April 09, 2024 | 1.392 |
| April 08, 2024 | 1.515 |
| April 05, 2024 | 1.567 |
| April 04, 2024 | 1.474 |
| April 03, 2024 | 1.598 |
| April 02, 2024 | 1.603 |
| April 01, 2024 | 1.731 |
| March 28, 2024 | 1.711 |
| Date | Value |
|---|---|
| March 27, 2024 | 2.008 |
| March 26, 2024 | 2.070 |
| March 25, 2024 | 1.906 |
| March 22, 2024 | 1.875 |
| March 21, 2024 | 1.670 |
| March 20, 2024 | 1.577 |
| March 19, 2024 | 1.639 |
| March 18, 2024 | 1.510 |
| March 15, 2024 | 1.515 |
| March 14, 2024 | 1.408 |
| March 13, 2024 | 1.392 |
| March 12, 2024 | 1.269 |
| March 11, 2024 | 1.305 |
| March 08, 2024 | 1.192 |
| March 07, 2024 | 1.325 |
| March 06, 2024 | 1.156 |
| March 05, 2024 | 1.156 |
| March 04, 2024 | 1.556 |
| March 01, 2024 | 1.130 |
| February 29, 2024 | 1.711 |
| February 28, 2024 | 1.110 |
| February 27, 2024 | 1.089 |
| February 26, 2024 | 1.089 |
| February 23, 2024 | 1.063 |
| February 22, 2024 | 1.043 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.4858
Minimum
Mar 24 2023
47.57
Maximum
Mar 25 2021
1.327
Average
1.003
Median
Dec 22 2021
Price to Book Value Benchmarks
| uniQure NV | 1.079 |
| ProQR Therapeutics NV | 3.592 |
| Merus NV | 7.939 |
| argenx SE | 5.637 |
| Pharming Group | 3.078 |
Price to Book Value Related Metrics
| PS Ratio | 12.05 |
| PEG Ratio | -0.0677 |
| Price | 3.05 |
| Earnings Yield | -51.48% |
| Market Cap | 80.18M |
| PEGY Ratio | -0.0677 |